Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
FDA approves drug combination for complicated intra-abdominal infections Dr. Kamal Kant Kohli14 Feb 2025 8:45 PM ISTAbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for adults with complicated...
AbbVie gets USFDA nod for Emblaveo for treatment of adults with complicated intra abdominal infections with limited or no treatment option Ruchika Sharma8 Feb 2025 11:30 AM ISTNorth Chicago: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a...
Pfizer gets CDSCO Panel nod to study antimicrobial FDC Avibactam plus Aztreonam Dr. Divya Colin30 Sept 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal to Study Aztreonam and Avibactam Dr. Divya Colin21 Sept 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Pfizer gets CDSCO Panel nod to import, and market Aztreonam plus Avibactam Powder Dr. Divya Colin2 Sept 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Justify Rationality of FDC Meropenem plus Sodium Carbonate plus Avibactam: CDSCO Panel Tells Akum Pharmaceutical Dr. Divya Colin2 May 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the drug major Akum Pharmaceutical, the Subject Expert Committee (SEC) functional under the Central...
Antibiotics combo promising against multidrug-resistant bacterial infections: Result from two phase 3 trials Medha Baranwal6 Jun 2023 10:45 AM ISTUSA: Findings from two phase 3 trials have shown the investigational antibiotic combination aztreonam-avibactam (ATM-AVI) to be safe and effective for...
Pfizer announces positive results from phase 3 studies of novel antibiotic combination aztreonam-avibactam in treating serious bacterial infections Ruchika Sharma4 Jun 2023 2:00 PM ISTNew York: Pfizer Inc. has announced positive results from the Phase 3 program comprising the REVISIT and ASSEMBLE studies evaluating the efficacy,...
